Cartesian Therapeutics, Inc. Share Price
NASDAQ: RNAC | Micro CapCartesian Therapeutics, Inc. Stock Performance
Cartesian Therapeutics, Inc. Share Price Today
As of 18 September 2026, Cartesian Therapeutics, Inc.'s share price is $7.94. The stock opened at $7.79, compared to its previous close of $7.85. During today's trading session, Cartesian Therapeutics, Inc.'s share price traded between $7.71 and $7.95, with an average price of $7.83. Over the past 52 weeks, the stock has recorded a high of $10.88 and a low of $5.66. In terms of performance, Cartesian Therapeutics, Inc.'s share price has risen by 28.58% over the last six months and is down 22.39% on a year-on-year basis.
Cartesian Therapeutics, Inc. Share Price Chart
About Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA CAR-T directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, an autologous anti-BCMA mRNA CAR-T to treat autoimmune diseases, such as relapsed/refractory multiple myeloma. The company is headquartered in Frederick, Maryland.
Cartesian Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $9.02 | $7.94 | -20.52% |
Aug 2026 | $7.86 | $9.99 | +28.74% |
Jul 2026 | $10.30 | $7.76 | -25.53% |
Jun 2026 | $7.43 | $10.42 | +38.56% |
May 2026 | $6.33 | $7.52 | +20.80% |
Apr 2026 | $6.38 | $6.22 | +0.81% |
Mar 2026 | $7.36 | $6.17 | -18.64% |
Feb 2026 | $6.96 | $7.59 | +10.16% |
Jan 2026 | $7.23 | $6.89 | -4.31% |
Dec 2025 | $7.30 | $7.20 | -4.26% |
Nov 2025 | $8.19 | $7.52 | -7.89% |
Oct 2025 | $10.10 | $8.16 | -20.20% |